SUNIL BABU
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology FORT WAYNE, IN NPI 1891968301
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology IN Acerta Pharma LLC All categories
General Payments — all program years on this page
$148,667.14
- Category: General Payments
- Program years: PY2018–2024
- Record count: 364
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $13,664.03 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,125.50 | 8 |
| Food and Beverage | $1,870.49 | 37 |
| Honoraria | $550.00 | 1 |
| Education | $118.04 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $3,282.50 | 3 |
| E.R. Squibb & Sons, L.L.C. | $2,515.21 | 5 |
| TAIHO ONCOLOGY, INC. | $2,100.00 | 1 |
| BeiGene USA, Inc. | $1,775.65 | 4 |
| GENZYME CORPORATION | $1,665.87 | 2 |
| Cornerstone Specialty Network LLC | $550.00 | 1 |
| Fennec Pharmaceuticals, Inc. | $394.06 | 2 |
| AVEO Pharmaceuticals, Inc. | $221.31 | 2 |
| ABBVIE INC. | $162.14 | 5 |
| Janssen Biotech, Inc. | $157.57 | 2 |
| Gilead Sciences, Inc. | $149.75 | 2 |
| Karyopharm Therapeutics Inc. | $128.58 | 2 |
| Rigel Pharmaceuticals, Inc. | $123.50 | 1 |
| Tempus AI, Inc | $121.25 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $80.11 | 3 |
| PFIZER INC. | $75.85 | 3 |
| Alexion Pharmaceuticals, Inc. | $64.75 | 2 |
| Adaptive Biotechnologies Corporation | $26.55 | 1 |
| Merck Sharp & Dohme Corporation | $24.78 | 2 |
| SERVIER PHARMACEUTICALS LLC | $22.29 | 1 |
| EISAI INC. | $19.70 | 1 |
| ARRAY BIOPHARMA INC | $2.61 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.